(Q34335538)

1 August 2017

title

Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes (English)

1 reference

cost-effectiveness analysis

1 August 2017

0 references

1 reference

1 reference

based on heuristic

inferred from title

author

Diabetes Prevention Program Research Group

series ordinal

1

object named as

Diabetes Prevention Program Research Group

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

1 August 2017

1 reference

1 August 2017

volume

26

1 reference

1 August 2017

issue

9

1 reference

1 August 2017

page(s)

2518-2523

1 reference

Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

A comprehensive league table of cost-utility ratios and a sub-table of "panel-worthy" studies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

The cost to health plans of poor glycemic control

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Health care expenditures for people with diabetes mellitus, 1992.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Value judgment in the Oregon Medicaid experiment.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Quality of life assessment for cost/utility studies in cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Effects of diet and exercise interventions on control and quality of life in non-insulin-dependent diabetes mellitus.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

A multicenter evaluation of a proprietary weight reduction program for the treatment of marked obesity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Behavior therapy for obesity: a comparative investigation of long-term efficacy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

The Quality of Well-Being Scale: critical similarities and differences with SF-36.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Interday reliability of function assessment for a health status measure. The Quality of Well-Being scale.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1360736

Individual versus group therapy for obesity: effects of matching participants to their treatment preferences

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12941712

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12941712

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2337/DIACARE.26.9.2518

1 reference

1 August 2017

1 reference

1 August 2017

1 reference